| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $289.4M | +43.9% |
| R&D Expense | $50.3M | +60.6% |
| SG&A Expense | $82.9M | +34.6% |
| Operating Income | -$30.2M | -128.0% |
| Interest Expense | $1.2M | -40.1% |
| Pre-tax Income | -$37.4M | -44.1% |
| Income Tax | $2.0M | -7.9% |
| Net Income | -$39.3M | -40.1% |
| EPS (Basic) | -$0.36 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $349.2M | -9.4% |
| Accounts Receivable | $13.7M | +5.6% |
| Current Assets | $450.6M | +1.5% |
| Total Assets | $674.3M | +5.4% |
| Current Liabilities | $177.3M | +50.9% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $192.4M | +22.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.4M | -68.3% |
| Capital Expenditures | $7.1M | +5.8% |
| Investing Cash Flow | -$24.7M | +60.8% |
| Financing Cash Flow | -$24.0M | -107.3% |
| Free Cash Flow | -$1.6M | -115.7% |
| +7.7% |
| EPS (Diluted) | -$0.36 | +7.7% |
| Stockholders' Equity |
| $481.9M |
| -0.1% |